Search - tctmd.com

Displaying 141 - 160 of 243

Sort: Relevancy | Date

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Opinion Editor's Corner EuroPCR 2022

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Shelley Wood

May 12, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2022

Shelley Wood

May 02, 2022

News Daily News

The NCDR Has Made a Difference, but Experts See Room for Growth

Todd Neale

April 28, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Daily News

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Michael O'Riordan

March 21, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Conference News STS 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

L.A. McKeown

February 02, 2022

Advertisement

What’s Going to Be Hot at ESC 2022?

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

August 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for June 2022

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Minorities, Poorer Patients Missing Out on Structural Heart Care

More Support for Single Antiplatelet Therapy After TAVI

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

TCTMD’s Top 10 Most Popular Stories for May 2022

June 2022 News Roundup

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

As TAVI Turns 20, How Has the Heart Team Evolved?

TCTMD’s Top 10 Most Popular Stories for April 2022

The NCDR Has Made a Difference, but Experts See Room for Growth

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 2022 News Roundup

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content